---
title: "EuroPCR 2025: DynamX coronary bioadaptor “durable” through three years"
date: "2025-05-21T19:31:35.000Z"
publishedDate: "21 mai 2025"
summary: "Elixir Medical has announced three-year results from the 445-patient BIOADAPTOR 1:1 randomised controlled trial (RCT), comparing the DynamX coronary bioadaptor system to Resolute Onyx (Medtronic) drug-eluting stent (DES) from 34 centres in Japan, Europe, and New Zealand. The results demonstrate sustained very low adverse events and durability of clinical outcomes with DynamX in target lesion [&#8230;] The post EuroPCR 2025: DynamX coronary bioadaptor “durable” through three years appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/europcr-2025-dynamx-coronary-bioadaptor-durable-through-three-years/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-05-21-europcr-2025-dynamx-coronary-bioadaptor-durable-through-three-years"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/IMG_9758-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2025-dynamx-coronary-bioadaptor-durable-through-three-years/"
---

![EuroPCR 2025: DynamX coronary bioadaptor “durable” through three years](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/IMG_9758-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2025-dynamx-coronary-bioadaptor-durable-through-three-years/*

## L’essentiel

Elixir Medical has announced three-year results from the 445-patient BIOADAPTOR 1:1 randomised controlled trial (RCT), comparing the DynamX coronary bioadaptor system to Resolute Onyx (Medtronic) drug-eluting stent (DES) from 34 centres in Japan, Europe, and New Zealand. The results demonstrate sustained very low adverse events and durability of clinical outcomes with DynamX in target lesion [&#8230;] The post EuroPCR 2025: DynamX coronary bioadaptor “durable” through three years appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/europcr-2025-dynamx-coronary-bioadaptor-durable-through-three-years/
